Jihan Grant, MD

Division Chief and Director
David S. and Ruth L. Gottesman Center for Headache Treatment and Translational Research at Mount Sinai

Poster(s):

• (E 23) Multisite pain burden measured by body map screening predicts reduced triptan responsiveness in adults with migraine, highlighting centralized pain mechanisms beyond formal COPC diagnoses.

• (T 35) Pharmacokinetic comparison of STS101 (Nasal DHE nasal powder) with liquid nasal spray, and injectable DHE formulations

• (T 39) Comparison of FDA approved intranasal acute migraine treatment adverse event profiles

• (TR 6) Reduced Cardiovagal activity is Strongly Associated with Treatment Resistance in Patients with Migraine